Literature DB >> 21880743

Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects.

Ravi Tandon1, Devi SenGupta, Lishomwa C Ndhlovu, Raphaella G S Vieira, R Brad Jones, Vanessa A York, Vinicius A Vieira, Elizabeth R Sharp, Andrew A Wiznia, Mario A Ostrowski, Michael G Rosenberg, Douglas F Nixon.   

Abstract

Human endogenous retrovirus (HERV)-specific T cell responses in HIV-1-infected adults have been reported. Whether HERV-specific immunity exists in vertically HIV-1-infected children is unknown. We performed a cross-sectional analysis of HERV-specific T cell responses in 42 vertically HIV-1-infected children. HERV (-H, -K, and -L family)-specific T cell responses were identified in 26 of 42 subjects, with the greatest magnitude observed for the responses to HERV-L. These HERV-specific T cell responses were inversely correlated with the HIV-1 plasma viral load and positively correlated with CD4(+) T cell counts. These data indicate that HERV-specific T cells may participate in controlling HIV-1 replication and that certain highly conserved HERV-derived proteins may serve as promising therapeutic vaccine targets in HIV-1-infected children.

Entities:  

Mesh:

Year:  2011        PMID: 21880743      PMCID: PMC3194955          DOI: 10.1128/JVI.05418-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

Review 1.  HIV-1: the infective process in vivo.

Authors:  J M McCune
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  Molecular investigations implicate human endogenous retroviruses as mediators of anti-retroviral antibodies in autoimmune rheumatic disease.

Authors:  P N Nelson; A M Lever; S Smith; R Pitman; P Murray; S A Perera; O M Westwood; F C Hay; H D Ejtehadi; J C Booth
Journal:  Immunol Invest       Date:  1999-07       Impact factor: 3.657

3.  HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses.

Authors:  S H Lewis; C Reynolds-Kohler; H E Fox; J A Nelson
Journal:  Lancet       Date:  1990-03-10       Impact factor: 79.321

4.  Retroviruses in rheumatic diseases.

Authors:  P N Nelson
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

5.  ERV-L elements: a family of endogenous retrovirus-like elements active throughout the evolution of mammals.

Authors:  L Bénit; J B Lallemand; J F Casella; H Philippe; T Heidmann
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

6.  Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus.

Authors:  K McIntosh; A Shevitz; D Zaknun; J Kornegay; P Chatis; N Karthas; S K Burchett
Journal:  Pediatr Infect Dis J       Date:  1996-12       Impact factor: 2.129

7.  Chromosomal assignment of human endogenous retrovirus K (HERV-K) env open reading frames.

Authors:  J Mayer; E Meese; N Mueller-Lantzsch
Journal:  Cytogenet Cell Genet       Date:  1997

8.  The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.

Authors:  L M Mofenson; J Korelitz; W A Meyer; J Bethel; K Rich; S Pahwa; J Moye; R Nugent; J Read
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

9.  Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV.

Authors:  K Boller; H König; M Sauter; N Mueller-Lantzsch; R Löwer; J Löwer; R Kurth
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

10.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

View more
  24 in total

1.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic.

Authors:  Jonah B Sacha; In-Jeong Kim; Lianchun Chen; Jakir H Ullah; David A Goodwin; Heather A Simmons; Daniel I Schenkman; Frederike von Pelchrzim; Robert J Gifford; Francesca A Nimityongskul; Laura P Newman; Samantha Wildeboer; Patrick B Lappin; Daisy Hammond; Philip Castrovinci; Shari M Piaskowski; Jason S Reed; Kerry A Beheler; Tharsika Tharmanathan; Ningli Zhang; Sophie Muscat-King; Melanie Rieger; Carla Fernandes; Klaus Rumpel; Joseph P Gardner; Douglas H Gebhard; Juliann Janies; Ahmed Shoieb; Brian G Pierce; Dusko Trajkovic; Eva Rakasz; Sing Rong; Michael McCluskie; Clare Christy; James R Merson; R Brad Jones; Douglas F Nixon; Mario A Ostrowski; Peter T Loudon; Ingrid M Pruimboom-Brees; Neil C Sheppard
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

3.  Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.

Authors:  R Brad Jones; Vivek M John; Diana V Hunter; Eric Martin; Shariq Mujib; Vesna Mihajlovic; Peter C Burgers; Theo M Luider; Gabor Gyenes; Neil C Sheppard; Devi Sengupta; Ravi Tandon; Feng-Yun Yue; Erika Benko; Colin Kovacs; Douglas F Nixon; Mario A Ostrowski
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

Review 4.  Human endogenous retrovirus-K (HML-2): a comprehensive review.

Authors:  Marta Garcia-Montojo; Tara Doucet-O'Hare; Lisa Henderson; Avindra Nath
Journal:  Crit Rev Microbiol       Date:  2018-10-14       Impact factor: 7.624

5.  Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences.

Authors:  Rafael Contreras-Galindo; Mark H Kaplan; Derek Dube; Marta J Gonzalez-Hernandez; Susana Chan; Fan Meng; Manhong Dai; Gilbert S Omenn; Scott D Gitlin; David M Markovitz
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

6.  HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.

Authors:  R Brad Jones; Keith E Garrison; Shariq Mujib; Vesna Mihajlovic; Nasra Aidarus; Diana V Hunter; Eric Martin; Vivek M John; Wei Zhan; Nabil F Faruk; Gabor Gyenes; Neil C Sheppard; Ingrid M Priumboom-Brees; David A Goodwin; Lianchun Chen; Melanie Rieger; Sophie Muscat-King; Peter T Loudon; Cole Stanley; Sara J Holditch; Jessica C Wong; Kiera Clayton; Erick Duan; Haihan Song; Yang Xu; Devi SenGupta; Ravi Tandon; Jonah B Sacha; Mark A Brockman; Erika Benko; Colin Kovacs; Douglas F Nixon; Mario A Ostrowski
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

7.  Polymorphic integrations of an endogenous gammaretrovirus in the mule deer genome.

Authors:  Daniel Elleder; Oekyung Kim; Abinash Padhi; Jason G Bankert; Ivan Simeonov; Stephan C Schuster; Nicola E Wittekindt; Susanne Motameny; Mary Poss
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

8.  HIV-1 Infection of Primary CD4+ T Cells Regulates the Expression of Specific Human Endogenous Retrovirus HERV-K (HML-2) Elements.

Authors:  George R Young; Sandra N Terry; Lara Manganaro; Alvaro Cuesta-Dominguez; Gintaras Deikus; Dabeiba Bernal-Rubio; Laura Campisi; Ana Fernandez-Sesma; Robert Sebra; Viviana Simon; Lubbertus C F Mulder
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

9.  HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.

Authors:  Neeru Bhardwaj; Frank Maldarelli; John Mellors; John M Coffin
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

10.  Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1.

Authors:  Kazuaki Monde; Rafael Contreras-Galindo; Mark H Kaplan; David M Markovitz; Akira Ono
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.